Certara, Inc. (CERT)
NASDAQ: CERT · Real-Time Price · USD
6.19
+0.01 (0.16%)
At close: May 4, 2026, 4:00 PM EDT
6.25
+0.06 (0.97%)
After-hours: May 4, 2026, 6:09 PM EDT
Certara Employees
As of December 31, 2025, Certara had 1,576 total employees, including 1,515 full-time and 61 part-time employees. The number of employees increased by 30 or 1.94% compared to the previous year.
Employees
1,576
Change (1Y)
30
Growth (1Y)
1.94%
Revenue / Employee
$265,760
Profits / Employee
-$1,012
Market Cap
949.08M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,576 | 30 | 1.94% | 1,515 | 61 |
| Dec 31, 2024 | 1,546 | 155 | 11.14% | 1,487 | 59 |
| Dec 31, 2023 | 1,391 | 187 | 15.53% | 1,338 | 53 |
| Dec 31, 2022 | 1,204 | 90 | 8.08% | 1,150 | 54 |
| Dec 31, 2021 | 1,114 | 211 | 23.37% | 1,054 | 60 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Teladoc Health | 5,600 |
| Evolent Health | 4,200 |
| Omnicell | 3,580 |
| Claritev | 3,000 |
| Phreesia | 1,789 |
| HealthStream | 1,160 |
| Omada Health | 916 |
| Weave Communications | 904 |
CERT News
- 12 days ago - Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Benzinga
- 12 days ago - Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat - GlobeNewsWire
- 12 days ago - Veristat to Acquire Certara's Regulatory and Medical Writing Business - Business Wire
- 25 days ago - Certara to Report First Quarter 2026 Financial Results on May 11th, 2026 - GlobeNewsWire
- 7 weeks ago - Certara Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 2 months ago - Certara Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Certara Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - GlobeNewsWire